NASDAQ: TRDAEntrada Therapeutics Inc Stock Ownership - Who owns Entrada Therapeutics?
Insider buying vs selling
Have Entrada Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Natarajan Sethuraman | President Research Develop. | 2025-09-02 | 1,760 | $5.43 | $9.56kSell |
| Nathan J. Dowden | President COO | 2025-09-02 | 1,746 | $5.43 | $9.48kSell |
| Dipal Doshi | CEO | 2025-09-02 | 8,723 | $5.43 | $47.37kSell |
| Kory James Wentworth | Chief Financial Officer | 2025-09-02 | 1,734 | $5.43 | $9.42kSell |
| 5am Ventures V LP | 10% Owner | 2025-07-09 | 6,935 | $7.50 | $52.03kSell |
| Kush Parmar | Director | 2025-07-09 | 6,935 | $7.50 | $52.03kSell |
| Kush Parmar | Director | 2025-07-09 | 20,065 | $7.50 | $150.53kSell |
| 5am Ventures V LP | 10% Owner | 2025-07-09 | 20,065 | $7.50 | $150.53kSell |
| Kush Parmar | Director | 2025-07-01 | 18,578 | $7.12 | $132.33kSell |
| 5am Ventures V LP | 10% Owner | 2025-07-01 | 18,578 | $7.12 | $132.33kSell |
TRDA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when TRDA insiders and whales buy or sell their stock.
TRDA Shareholders
What type of owners hold Entrada Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Kush Parmar | 14.17% | 5,388,736 | $27.59M | Insider |
| 5am Ventures V LP | 14.17% | 5,388,736 | $27.59M | Insider |
| Baker Bros Advisors LP | 12.79% | 4,865,819 | $24.91M | Institution |
| Baker Bros Advisors LP | 11.83% | 4,501,658 | $23.05M | Insider |
| Todd Foley | 11.64% | 4,425,784 | $22.66M | Insider |
| Mpm Bioventures 2018 LP | 11.52% | 4,381,062 | $22.43M | Insider |
| Mpm Bioventures 2014 LP | 11.52% | 4,381,062 | $22.43M | Insider |
| Mpm Asset Management LLC | 11.52% | 4,381,062 | $22.43M | Institution |
| 5am Venture Management LLC | 11.33% | 4,308,379 | $22.06M | Institution |
| Roche Holding Ltd | 7.40% | 2,813,525 | $14.41M | Insider |
TRDA vs Biotech Stocks
Entrada Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.